Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This observational study in middle-aged women aimed to evaluate the efficacy and safety of omega-3 fatty acids in treating telogen effluvium, but results specific to these outcomes were not provided.

This review discusses telogen effluvium, including its triggers, clinical presentations, and management options, and does not report new research findings, emphasizing the need for identification and exclusion of underlying causes.

This review discusses telogen effluvium as a common cause of diffuse hair loss and reports no new clinical results, noting diagnostic and treatment challenges.

In this study, pegylated interferon alpha therapy was independently associated with more severe hair loss, particularly acute telogen effluvium, in chronic hepatitis B patients with alopecia, compared to nucleos(t)ide analog therapy, emphasizing the importance of monitoring and counseling, especially for younger female patients.

This case report describes an 85-year-old woman who developed localized telogen effluvium, a form of temporary hair loss, three months after Mohs micrographic surgery for basal cell carcinoma on her scalp, with complete hair regrowth achieved through minoxidil therapy within ten months.

This study found that patients who were hospitalized for COVID-19 were more likely to develop telogen effluvium, a type of hair loss, compared to those treated as outpatients, suggesting a link between COVID-19 severity and this condition.

This review explores the potential connection between GA and various types of alopecia but reports no new clinical findings, emphasizing the need for further research.

This narrative review identifies telogen effluvium as a growing concern linked to weight-loss interventions, such as GLP-1 receptor agonists and bariatric surgery, attributing hair loss to systemic and metabolic stress rather than permanent hair follicle damage.

This article reviews evidence-based complementary strategies to enhance hair regrowth after post-COVID-19 telogen effluvium, emphasizing psychological support, patient education, nutrition, and both topical and injectable hair growth stimulators.

This study found that treatments with 5% minoxidil, with or without latanoprost, were effective in controlling hair loss and increasing hair strand count in patients with telogen effluvium or androgenic alopecia.

This report describes a case where severe hair loss occurred as an early manifestation of Hodgkin disease, with the literature suggesting it might result from follicle destruction or toxic effects.

This consensus paper reviews expert opinions on treating telogen effluvium but reports no new clinical findings.

This study found that applying amaranthus extract cream to the scalp significantly improved terminal hair density, anagen hair count, and pilary index in men with male pattern hair loss, suggesting it may be a safe and effective supportive therapy.

This study found that among female patients with acute telogen effluvium, 83.7% reported either partial or complete resolution of hair shedding after three months of treatment including vitamin E and zinc supplements.

This systematic review reports that acute telogen effluvium may occur as a stress-induced hair loss following COVID-19 recovery, with most patients experiencing hair regrowth over time.

This research retrospectively evaluated 92 skin specimens to propose histopathological criteria for diagnosing alopecia areata incognito, distinguishing it from telogen effluvium and androgenetic alopecia.

In this study, increased protein intake during modified fasting nearly eliminated hair loss observed in patients with significant weight loss and negative nitrogen balance.

This review focuses on the medical treatment of common nonscarring alopecias, including androgenetic alopecia, alopecia areata, and telogen effluvium, and reports no new clinical results.

This source reports that two noninvasive tests, the pull test and a modified wash test, can help diagnose and determine the severity of different types of hair loss in women by assessing hair shedding and characteristics, offering a simple and cost-effective evaluation method.

In this study, nine individuals who underwent rigorous weight loss programs experienced significant hair loss, which researchers attributed to insufficient energy supply to the hair matrix, with regrowth occurring within months.

This study reported that etretinate treatment leads to increased hair shedding due to a sustained decrease in anagen duration, with an arrest at the onset of anagen and a follicular anchorage defect in telogen contributing to alopecia.

This study demonstrated that using morphometric and 3D reconstruction software to evaluate scalp biopsies in non-cicatricial alopecias may be feasible and sensitive for detecting subtle follicular changes.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

This study found that clinically non-affected perilesional scalp in Japanese alopecia patients often showed microscopic abnormalities, which may help in assessing the spread of disease activities.

A woman with Parry-Romberg syndrome developed new curly hair on one side of her scalp, a condition not previously linked to the syndrome.

This study found that patients with systemic lupus erythematosus and diffuse hair loss showed non-scarring alopecia without inflammation and a decrease in total hair follicles.

This report describes a unique case of dyschromatosis universalis in a 10-year-old Haitian male, notable for the presence of a silvery sheen to his scalp hairs and eyelashes, which may represent a variation of the condition.

This communication discusses previous reports of deadly hematopoietic depression associated with the topical use of demecolcine for skin cancers, highlighting potential hazards relative to colchicine ointment in psoriasis.

This study found that finasteride increases anagen hair growth in men with androgenetic alopecia.

This article reviews various topics discussed at a workshop on hair disorders, focusing on hair biology, diagnosis, and challenges in therapy evaluation, without presenting new clinical findings.